Michael J. Clark
  • Assistant Professor
  • General Pediatrics
General Pediatrics, Adult Medicine
Board Certifications
  • Internal Medicine - General Cert: AM Board of Internal Medicine
  • Pediatrics - General Cert: AM Board of Pediatrics

Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implicationsRamacciotti,E.; Clark,M.; Sadeghi,N.; Hoppensteadt,D.; Thethi,I.; Gomes,M.; Fareed,J.Clinical & Applied Thrombosis/Hemostasis 2011 ;17(2):126-135

Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.Li,B.; Suwan,J.; Martin,J. G.; Zhang,F.; Zhang,Z.; Hoppensteadt,D.; Clark,M.; Fareed,J.; Linhardt,R. J.Biochemical pharmacology 2009 ;78(3):292-300

Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.Clark,M.; Hoppensteadt,D.; Walenga,J. M.; Myers,L.; Cunanan,J.; Jeske,W.; Adiguzel,C.; Iqbal,O.; Fareed,J.International Angiology 2008 ;27(5):370-376

Are all low molecular weight heparins equivalent in the management of venous thromboembolism?Fareed,J.; Jeske,W.; Fareed,D.; Clark,M.; Wahi,R.; Adiguzel,C.; Hoppensteadt,D.Clinical & Applied Thrombosis/Hemostasis 2008 ;14(4):385-392

Biological Profile of the Hyper/Oversulfated Chondroitin Sulfate Contaminant Isolated from Recalled HeparinFareed,J.; Walenga,J. M.; Jeske,W. P.; Hoppensteadt,D.; Prechel,M.; Iqbal,O.; Adiguzel,C.; Clark,M.; Litinas,E.; cunanan,J.; Linhardt,R.; Harenberg,J.Seminars in thrombosis and hemostatis 2008 ;34(supplement 1):119-127

Academy Consensus Conference on Postoperative management of the lower extremity amputee.Smith,D. G.; Berke,G. M.; Blanck,R.; Bianchi,C.; Clark,M. W.; Ertl,J. P.; Pinzur,M. S.; Wu,Y.JPO 2004 ;16(3S):2

Medical School
  • University of Illinois College of Medicine
  • University of Illinois at Chicago Medical Center, Internal Medicine & Pediatrics